Disclosures for "INTERCEPT-AD Biomarker Results: Early Effect of Sabirnetug Treatment on Synaptic Biomarkers in Alzheimer's Disease"
-
Dr. Johnson has received personal compensation for serving as an employee of Acumen Pharmaceuticals.
-
Dr. Cline has received personal compensation for serving as an employee of Acumen Pharmaceuticals. Dr. Cline has stock in Acumen Pharmaceuticals.
-
Karen Sundell has received personal compensation for serving as an employee of Acumen Pharmaceuticals . Karen Sundell has stock in Acumen Pharmaceuticals .
-
Dr. Antwi-Berko has nothing to disclose.
-
Dr. Koel-Simmelink has nothing to disclose.
-
Prof. Teunissen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Prof. Teunissen has received publishing royalties from a publication relating to health care.
-
Dr. Siemers has received personal compensation for serving as an employee of Acumen Pharmaceuticals. The institution of Dr. Siemers has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Vaccinex Pharmceuticals. The institution of Dr. Siemers has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cogstate Ltd. The institution of Dr. Siemers has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Gates Ventures LLC. The institution of Dr. Siemers has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for US Green Valley Pharmaceuticals, Inc. Dr. Siemers has stock in Acumen Pharmaceuticals. Dr. Siemers has stock in Ell Lilly and Company. Dr. Siemers has received personal compensation in the range of $0-$499 for serving as a study section reviewer with National Institutes of Health. Dr. Siemers has a non-compensated relationship as a Volunteer with Alzheimer's Association that is relevant to AAN interests or activities. Dr. Siemers has a non-compensated relationship as a Board of Directors with Bright Focus Foundation that is relevant to AAN interests or activities. Dr. Siemers has a non-compensated relationship as a Board of Directors with Huntington Study Group that is relevant to AAN interests or activities.
-
Dr. Zhang has received personal compensation for serving as an employee of Acumen Pharmaceuticals.
-
Miss Hyland has received personal compensation for serving as an employee of Acumen Pharmaceuticals.
-
Dr. Sethuraman has received personal compensation for serving as an employee of Acumen Pharmaceuticals. Dr. Sethuraman has stock in Acumen Pharmaceuticals.
-
Dr. Vanderstichele has received personal compensation in the range of $0-$499 for serving as a Consultant for Acumenpharm.
-
Dr. kaplow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Acumen Pharmaceuticals Inc.
-
Robert A. Dean has received personal compensation for serving as an employee of Acumen Pharmaceutics. Robert A. Dean has received personal compensation for serving as an employee of Gates Ventures. Robert A. Dean has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Robert A Dean Consulting, LLC. Robert A. Dean has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.
-
Dr. Jerecic has received personal compensation for serving as an employee of Acumen Pharmaceuticals Inc.